The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Target discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Mass spectrometry-based proteomics
Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Systems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
The International SNP Map Working Group, Laboratories:, C. S. H., Sachidanandam, R., Weissman, D., Schmidt, S. C., Kakol, J. M., Stein, L. D., National Center for Biotechnology Information:, Marth, G., Sherry, S., et al. (2001) · Nature · doi:10.1038/35057149 · Cited by 2,977
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
A comprehensive review of genetic association studies
Hirschhorn, J. N., Lohmueller, K., Byrne, E., & Hirschhorn, K. (2002) · Genetics in Medicine · doi:10.1097/00125817-200203000-00002 · Cited by 1,674
Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J., Rooney, D. L., Zhang, M., Ihrig, M. M., McManus, M. T., et al. (2003) · Nature Genetics · doi:10.1038/ng1117 · Cited by 1,501
Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., & Lebleu, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209548200 · Cited by 1,446
Analysis of gene function in somatic mammalian cells using small interfering RNAs
Elbashir, S. (2002) · Methods · doi:10.1016/s1046-2023(02)00023-3 · Cited by 1,095
Candidate-gene approaches for studying complex genetic traits: practical considerations
Tabor, H. K., Risch, N. J., & Myers, R. M. (2002) · Nature Reviews Genetics · doi:10.1038/nrg796 · Cited by 1,076
RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells
Yu, J.-Y., DeRuiter, S. L., & Turner, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092143499 · Cited by 1,039
Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research
Gehl, J. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01093.x · Cited by 973
Random Peptide Libraries: a Source of Specific Protein Binding Molecules
Devlin, J. J., Panganiban, L. C., & Devlin, P. E. (1990) · Science · doi:10.1126/science.2143033 · Cited by 922
Ratjen, F., & Döring, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12567-6 · Cited by 885
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785
Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor
Holen, T. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.8.1757 · Cited by 706
Genome-wide, large-scale production of mutant mice by ENU mutagenesis
de Angelis, M. H., Flaswinkel, H., Fuchs, H., Rathkolb, B., Soewarto, D., Marschall, S., Heffner, S., Pargent, W., Wuensch, K., Jung, M., et al. (2000) · Nature Genetics · doi:10.1038/78146 · Cited by 664
Nolan, P. M., Peters, J., Strivens, M., Rogers, D., Hagan, J., Spurr, N., Gray, I. C., Vizor, L., Brooker, D., Whitehill, E., et al. (2000) · Nature Genetics · doi:10.1038/78140 · Cited by 654
Protein analysis on a proteomic scale
Phizicky, E., Bastiaens, P. I. H., Zhu, H., Snyder, M., & Fields, S. (2003) · Nature · doi:10.1038/nature01512 · Cited by 629
LNA: a versatile tool for therapeutics and genomics
Petersen, M., & Wengel, J. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(02)00038-0 · Cited by 613
The genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
From patterns to pathways: gene expression data analysis comes of age
Slonim, D. K. (2002) · Nature Genetics · doi:10.1038/ng1033 · Cited by 572
Protein transduction technology
Wadia, J. S., & Dowdy, S. F. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00284-7 · Cited by 483
The use and analysis of microarray data
Butte, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd961 · Cited by 483
Non-viral gene delivery systems
Davis, M. E. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00294-x · Cited by 419
Knockouts model the 100 best-selling drugs—will they model the next 100?
Zambrowicz, B. P., & Sands, A. T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd987 · Cited by 393
Lentiviral-Mediated RNA Interference
Abbas-Terki, T., Blanco-Bose, W., Déglon, N., Pralong, W., & Aebischer, P. (2002) · Human Gene Therapy · doi:10.1089/104303402320987888 · Cited by 284
Inflammation and therapeutic vaccination in CNS diseases
Weiner, H. L., & Selkoe, D. J. (2002) · Nature · doi:10.1038/nature01325 · Cited by 255
Horrobin, D. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1012 · Cited by 248
Novel Antisense and Peptide Nucleic Acid Strategies for Controlling Gene Expression
Braasch, D. A., & Corey, D. R. (2002) · Biochemistry · doi:10.1021/bi0122112 · Cited by 248
Goldstein, J. L., & Brown, M. S. (2001) · Science · doi:10.1126/science.1061815 · Cited by 241
Pharmacological strategies for muscular dystrophy
Khurana, T. S., & Davies, K. E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1085 · Cited by 225
Target selection in drug discovery
Knowles, J., & Gromo, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd986 · Cited by 216
Peptide-mediated cell delivery: application in protein target validation
Lindsay, M. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00199-6 · Cited by 175
Self-citationBarnett, B. G., Crews, C. J., & Douglas, J. T. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00249-x · Cited by 174
Templin, M. F., Stoll, D., Schrenk, M., Traub, P. C., Vöhringer, C. F., & Joos, T. O. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01910-2 · Cited by 173
Better therapeutics through microarrays
Gerhold, D. L., Jensen, R. V., & Gullans, S. R. (2002) · Nature Genetics · doi:10.1038/ng1042 · Cited by 141
RNAi: gene-silencing in therapeutic intervention
Shuey, D. J., McCallus, D. E., & Giordano, T. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02474-1 · Cited by 132
Is proteomics heading in the wrong direction?
Huber, L. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1007 · Cited by 130
Huntingtin in health and disease.
Young, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17742 · Cited by 125
Lentiviral Vectors for Gene Delivery into Cells
Quinonez, R. A., & Sutton, R. E. (2002) · DNA and Cell Biology · doi:10.1089/104454902762053873 · Cited by 114
Weisburger, J. H. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00400-7 · Cited by 108
Romero, R. J., Kuivaniemi, H., Tromp, G., & Olson, J. M. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.128319 · Cited by 107
Forward chemical genetics: progress and obstacles on the path to a new pharmacopoeia
Lokey, R. S. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00002-9 · Cited by 105
Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.
Seth, A. K., Kitching, A. R., Landberg, G., Xu, J., Zubovits, J. T., & Burger, A. M. (2003) · PubMed · Cited by 98
Phage Display of Antibody Fragments
Pini, A., & Bracci, L. (2000) · Current Protein and Peptide Science · doi:10.2174/1389203003381397 · Cited by 97
Gene Delivery Using Herpes Simplex Virus Vectors
Burton, E. A., Fink, D. J., & Glorioso, J. C. (2002) · DNA and Cell Biology · doi:10.1089/104454902762053864 · Cited by 92
Functional genomics and target validation approaches using antisense oligonucleotide technology
Dean, N. M. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(01)00270-1 · Cited by 80
Protein transduction domains: are they delivering?
Green, I., Christison, R., Voyce, C. J., Bundell, K. R., & Lindsay, M. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00076-2 · Cited by 78
Self-citationGrillone, L. R., & Lanz, R. (2001) · Drugs of today · doi:10.1358/dot.2001.37.4.620590 · Cited by 69
A Growing Network of Cancer-Susceptibility Genes
Venkitaraman, A. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmcibr023150 · Cited by 65
In vivo drug target discovery: identifying the best targets from the genome
WALKE, D. W., Han, C., Shaw, J., Wann, E. R., Zambrowicz, B., & Sands, A. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(01)00271-3 · Cited by 48
Full-speed mammalian genetics: in vivo target validation in the drug discovery process
Abuin, A., Holt, K. H., Platt, K. A., Sands, A., & Zambrowicz, B. (2002) · Trends in biotechnology · doi:10.1016/s0167-7799(01)01843-1 · Cited by 46
Transgenic systems in drug discovery: from target identification to humanized mice
Törnell, J., & Snaith, M. R. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02234-1 · Cited by 42
Designed transcription factors as tools for therapeutics and functional genomics
Urnov, F. D., & Rebar, E. J. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01150-4 · Cited by 38
Grimsditch, D. C., Penfold, S., Latcham, J., Vidgeon-Hart, M., Groot, P. H. E., & Benson, G. M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00400-1 · Cited by 35
Lorens, J. B., Sousa, C., Bennett, M. K., Molineaux, S. M., & Payan, D. G. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(01)00269-5 · Cited by 34
Using model-system genetics for drug-based target discovery
Matthews, D. J., & Kopczynski, J. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01612-3 · Cited by 32
Effects of β2-agonists on airway tone and bronchial responsiveness
Larj, M. J., & Bleecker, E. R. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.130045 · Cited by 28
Hammerhead ribozymes for target validation
Goodchild, J. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.2.235 · Cited by 11
Cited by
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
In vivo drug discovery in the zebrafish
Zon, L. I., & Peterson, R. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1606 · Cited by 1,353
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
The Connectivity Map: A new tool for biomedical research
Lamb, J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2044 · Cited by 945
Multidimensional Drug Profiling By Automated Microscopy
Perlman, Z. E., Slack, M. D., Feng, Y., Mitchison, T. J., Wu, L. F., & Altschuler, S. J. (2004) · Science · doi:10.1126/science.1100709 · Cited by 660
Metadata
- Authors
- Lindsay, M. A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-10
- Volume
- 2
- Issue
- 10
- Pages
- 831-838
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W4240545411
- Cited by
- 332
- References
- 64
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.